![Chapitre 5. Du familial au collectif : mémoires (post-)migratoires dans l'Atlas et l'Est marocains, l'île de Skye (Écosse) et la vallée de l'Ubaye (France) | Cairn.info Chapitre 5. Du familial au collectif : mémoires (post-)migratoires dans l'Atlas et l'Est marocains, l'île de Skye (Écosse) et la vallée de l'Ubaye (France) | Cairn.info](https://www.cairn.info/vign_rev/PUG_MOIN/PUG_OIRY_2019_01.jpg)
Chapitre 5. Du familial au collectif : mémoires (post-)migratoires dans l'Atlas et l'Est marocains, l'île de Skye (Écosse) et la vallée de l'Ubaye (France) | Cairn.info
![BusinessWire - Celgene Corporation (CG3) FDA Grants Approval of IDHIFA®, the First Oral Targeted Therapy for Adult Patients with Relapsed/Refractory Acute Myeloid Leukemia and an IDH2 Mutation | ResearchPool BusinessWire - Celgene Corporation (CG3) FDA Grants Approval of IDHIFA®, the First Oral Targeted Therapy for Adult Patients with Relapsed/Refractory Acute Myeloid Leukemia and an IDH2 Mutation | ResearchPool](https://mms.businesswire.com/media/20170801006281/en/604221/4/AML_infographic_8117---FINAL.jpg)
BusinessWire - Celgene Corporation (CG3) FDA Grants Approval of IDHIFA®, the First Oral Targeted Therapy for Adult Patients with Relapsed/Refractory Acute Myeloid Leukemia and an IDH2 Mutation | ResearchPool
![BusinessWire - Acacia Research Corp. - Acacia Technologies (ACTG) Acacia Research Corporation Board of Directors Files its Definitive Proxy Materials and Issues Letter to Stockholders | ResearchPool BusinessWire - Acacia Research Corp. - Acacia Technologies (ACTG) Acacia Research Corporation Board of Directors Files its Definitive Proxy Materials and Issues Letter to Stockholders | ResearchPool](https://mms.businesswire.com/media/20180514005603/en/657334/4/Acacia--1.jpg)